Rachel Goodwin
Overview
Explore the profile of Rachel Goodwin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer Centres
Nair G, Black M, Baer K, Welch S, Laidley D, Goodwin R, et al.
Curr Oncol
. 2025 Feb;
32(2).
PMID: 39996886
Pancreatic neuroendocrine tumors (pNETs) are rare but increasingly prevalent malignancies with varied prognoses and a diverse range of treatment options, including surgery, somatostatin analogues (SSAs), chemotherapy, targeted therapy, and peptide...
2.
Martin J, Alrehaili M, Marginean H, Goodwin R, Wheatley-Price P
Cancer Treat Res Commun
. 2024 Oct;
41:100846.
PMID: 39366307
Introduction: Lung neuroendocrine tumours (LNETs) are a rare heterogenous group of tumours whose incidence has been increasing. We investigated the diagnosis, treatment, and survival patterns of patients with low to...
3.
Loree J, Chan D, Lim J, Stuart H, Fidelman N, Koea J, et al.
JAMA Oncol
. 2024 Oct;
10(12):1707-1720.
PMID: 39361298
Importance: Evidence-based treatment decisions for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) require individualized patient-centered decision-making that accounts for patient and cancer characteristics. Objective: To create an accessible guidance document to educate...
4.
Alrehaili M, Phillips W, Asmis T, Vickers M, Marginean H, Goodwin R
Oncology
. 2024 Sep;
:1-6.
PMID: 39321784
Introduction: The incidence of neuroendocrine tumors (NETs) is rising. Our objective was to assess trends in gastroenteropancreatic (GEP)-NETs diagnosis (June 2010 to June 2021) at TOHCC and to explore whether...
5.
Phillips W, Pradier M, Goodwin R, Vickers M, Asmis T
Curr Oncol
. 2024 Feb;
31(2):952-961.
PMID: 38392065
Introduction: The COVID-19 pandemic resulted in an unprecedent shift towards virtual cancer care, including the care of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The aim of this study was to evaluate the...
6.
Solar Vasconcelos J, Chen N, Titmuss E, Tu D, Brule S, Goodwin R, et al.
Clin Cancer Res
. 2024 Jan;
30(6):1121-1130.
PMID: 38170586
Purpose: Sidedness is prognostic and predictive of anti-EGFR efficacy in metastatic colorectal cancer (mCRC). Transverse colon has been historically excluded from several analyses of sidedness and the optimal division between...
7.
Al-Mansor E, Mahoney M, Chenard-Poirier M, Ramjeesingh R, Nair V, Kennedy E, et al.
Curr Oncol
. 2023 Sep;
30(9):8172-8185.
PMID: 37754508
The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023 was held in Quebec City, Quebec 2-4 February 2023. The purpose of the conference was to develop consensus statements on emerging...
8.
Alfagih A, AlJassim A, Alqahtani N, Vickers M, Goodwin R, Asmis T
Curr Oncol
. 2023 Aug;
30(8):7508-7519.
PMID: 37623025
(1) Aim: The prevalence and incidence of small bowel NETs have increased significantly over the past two decades. This study aims to report the 10-year experience of SB-NET management at...
9.
Ramjeesingh R, Chaudhury P, Tam V, Roberge D, Lim H, Knox J, et al.
Curr Oncol
. 2023 Aug;
30(8):7132-7150.
PMID: 37622998
Biliary tract cancers (BTC) are rare and aggressive tumors with poor prognosis. Radical surgery offers the best chance for cure; however, most patients present with unresectable disease, and among those...
10.
Biagi J, Cosby R, Bahl M, Elfiki T, Goodwin R, Hallet J, et al.
Curr Oncol
. 2023 Jul;
30(7):6575-6586.
PMID: 37504342
Pancreatic cancer is the seventh leading cause of cancer deaths worldwide, accounting for 4.7% of all cancer deaths, and is expected to climb significantly over the next decade. The purpose...